Secretion of Glucagon-like peptide-1 (GLP-1), Glucose-dependent insulinotropic polypeptide (GIP), insulin and glucagon and glucose disposal in patients with NAFLD and NASH vs. controls in response to oral glucose tolerance test. Here, GLP1R is linked to metabolic dysfunction-associated steatohepatitis.